You have clicked a link to access information on a new website, so you will be leaving Because this new site is independent, Diamond Hill Capital Management, Inc. neither manages nor assumes responsibility for its content. Are you ready to move forward?

COVID-19 & the Health Care Industry

Health care analysts Chendhore Veerappan and Laura O’Dell discuss treatments health care companies are developing for COVID-19, how they’re ramping up testing capacity and what the virus means for health care holdings in our portfolios.

The views expressed are those of Diamond Hill as of April 2020 and are subject to change. These opinions are not intended to be a forecast of future events, a guarantee of results, or investment advice.

As of March 31, 2020 Diamond Hill owned Abbott Laboratories (equity), GlaxoSmithKline PLC (equity), Pfizer, Inc. (equity), Gilead Sciences, Inc. (equity), Roche Holdings AG (equity) and Thermo Fisher Scientific, Inc. (equity). As of January 31, 2020 Diamond Hill owned AbbVie, Inc. (debt) and Abbott Laboratories (debt).

back to top